Search results (1320)
« Back to PublicationsPost hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanoma
middleton MR. et al, (2000), Journal of Clinical Oncology, 18, 1474 - 1480
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
Middleton MR. et al, (2000), Journal of Clinical Oncology, 18, 158 - 166
O(6)-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts.
Middleton MR. et al, (2000), Int J Cancer, 85, 248 - 252
O-6-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts
Middleton MR. et al, (2000), INTERNATIONAL JOURNAL OF CANCER, 85, 248 - 252
Four-hourly scheduling of temozolomide improves tumour growth delay but not therapeutic index in A375M melanoma xenografts.
Middleton MR. et al, (2000), Cancer Chemother Pharmacol, 45, 15 - 20
Phase II trial of 4-hourly temozolomide (TMZ) in advanced malignant melanoma (MM)
Arance A. et al, (1999), EUROPEAN JOURNAL OF CANCER, 35, S371 - S371
Adjuvant interferon in the treatment of melanoma.
Middleton MR., (1999), Br J Cancer, 80, 1679 - 1680
Reducing incidence of headache after lumbar puncture and intrathecal cytotoxics.
Lo SK. et al, (1999), Lancet, 353, 2038 - 2039
Inactivation of O6-alkylguanine-DNA alkyltransferase. 1. Novel O6-(hetarylmethyl)guanines having basic rings in the side chain.
McElhinney RS. et al, (1998), J Med Chem, 41, 5265 - 5271
O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma.
Middleton MR. et al, (1998), Br J Cancer, 78, 1199 - 1202
A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer.
Jayson GC. et al, (1998), Br J Cancer, 78, 366 - 369
Dose intensity in small cell lung cancer
Thatcher N. et al, (1998), Seminars in Oncology, 25, 12 - 18
Dose intensity in small cell lung cancer
Thatcher N. et al, (1998), SEMINARS IN ONCOLOGY, 25, 12 - 18
Encephalopathy and haemorrhagic mucositis after high-dose melphalan with peripheral blood stem cell rescue in two patients with impaired renal function
Schuh AH. et al, (1998), BONE MARROW TRANSPLANTATION, 21, S202 - S202
Consequences of GATA-1 deficiency in megakaryocytes and platelets.
Vyas P. et al, (1998), BLOOD, 92, 195A - 195A
Dose intensification in small cell lung cancer chemotherapy
Middleton MR. and Thatcher N., (1998), Emerging Drugs, 3, 293 - 302
Hippocampal and cortical G protein (Gs alpha, G(o) alpha and Gi2 alpha) mRNA expression after electroconvulsive shock or lithium carbonate treatment.
McGowan S. et al, (1996), Eur J Pharmacol, 306, 249 - 255
Repeated ECS differentially affects rat brain 5-HT1A and 5-HT2A receptor expression.
Burnet PW. et al, (1995), Neuroreport, 6, 901 - 904